Biorocks

Private

ShenzhenHealthcare & Life Scienceshttps://biorocks.net/

Last Round

Series A

Extension

Jan 4, 2023

Total Funding Raised

$6.3M

Company Overview

Biorocks is a biotechnology company that develops and manufactures automated, microfluidics-based systems for embryo cryopreservation and warming to improve the consistency and efficiency of assisted reproductive technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

vitrificationassisted reproductive technologyARTembryo cryopreservationIVF laboratory equipmentmicrofluidicsoocyte vitrificationfertility techautomated vitrificationlab automationlivestock breedingfertility clinic equipmentbiotech hardwareembryo transfer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biorocks Comps

Public and private peers based on sector, stage, and business model.

Biorocks comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biorocks Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jan 4, 2023
Series A	Oct 1, 2022
Early Funding	Jan 1, 2022
Early Funding	Aug 1, 2021
Angel	Jun 1, 2021

View all Funding Rounds

Biorocks Investors

Notable investors and investment history

Biorocks investors
Investor	Rounds
Shenzhen Credit Guarantee Group	Series A Extension
清科资本	Series A Extension
Shenzhen Sunhope Investment Development Co., Ltd.	Early Funding
联想创投集团 (Lenovo Capital and Incubator Group)	Series A
Zero2IPO Venture Capital	Early Funding
Zero2IPO Group	Early Funding
Shenzhen HTI Group	Early Funding

View all Investors

Biorocks Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biorocks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biorocks's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen

Year Founded2017

Last FundingJan 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.